retatrutide and nad+ together vs. Tirzepatide: The Next-Gen GLP-1 Showdown Retatrutide Side Effects 2026

Research-grade peptides are not manufactured under the same quality standards as pharmaceutical-grade compounds and are not intended for human use

The key consideration is timing and duration

And heres another eye-opening statistic: 63 percent of people stop using GLP-1 shots within the first month because of uncomfortable side effects like nausea, constipation, and diarrhea

Even when performed in compounding pharmacies, the risk of contamination exceeds that of FDA-approved pre-filled pens manufactured under current Good Manufacturing Practice (cGMP) standards

However, the heart rate increase associated with retatrutide complicates this picture

As the world of weight management evolves, many are looking for alternatives to traditional fat-burning methods like calorie restriction and exercise alone